https://www.selleckchem.com/pr....oducts/pamapimod-r-1
will successfully recruit 24 participants and the intervention will be acceptable to the participants. It will also improve medication adherence (assessed by question Medication Adherence Questionnaire scores) and blood pressure control. Our study was funded in July 2020. As of May 2021, we have enrolled 6 participants. Our findings will help design a larger efficacy trial to advance the field of eHealth delivery systems particularly for older adults of low socioeconomic status. This study addresses a highly significa
Like
Comment
Share
